🟢 Aquestive Therapeutics is trading 5% up in pre-market as Nasdaq Composite gains 0.52%

Aquestive Therapeutics is trading at $5.07, up 5.48%, with the move appearing aligned with a firm pre-market backdrop.

• No new company-specific announcement was found for September 16, 2026.
• Recent coverage centers on Anaphylm’s planned FDA resubmission this month.
• Nasdaq Composite is up 0.52%; shares declined from $5.34 on September 4 to $4.81 on September 15.